Multicenter Trial of ESK981 in Patients With Select Solid Tumors
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Novartis
Eisai Inc.
Advanced Accelerator Applications
Advanced Accelerator Applications
University of Washington
RayzeBio, Inc.
University of Washington
Imperial College London
ITM Solucin GmbH
Perspective Therapeutics
Camurus AB
Hospices Civils de Lyon
Assistance Publique - Hôpitaux de Paris
ITM Solucin GmbH
RayzeBio, Inc.
Stanford University
National Health Research Institutes, Taiwan
Case Comprehensive Cancer Center
PharmaMar
Advanced Accelerator Applications
Grupo Espanol de Tumores Neuroendocrinos
Aadi Bioscience, Inc.
University Hospital, Antwerp
University Hospital, Basel, Switzerland
Rigshospitalet, Denmark
Institut Bergonié
British Columbia Cancer Agency
University of Maryland, Baltimore
Ipsen
University of Wisconsin, Madison
Henan Cancer Hospital
Jiangsu HengRui Medicine Co., Ltd.
Insel Gruppe AG, University Hospital Bern